Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
59.72
-0.44 (-0.73%)
Aug 10, 2026, 4:00 PM EDT - Market closed

Inspire Medical Systems Stock Forecast

Stock Price Forecast

According to 17 analysts polled by S&P Global, Inspire Medical Systems stock has a consensus rating of "Hold" and an average price target of $60.4. The average 1-year stock price forecast is 1.14% higher than the current stock price, while the lowest is $40 (-33.02%) and the highest is $85 (+42.33%).

Price Target: $60.4 (+1.14%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$40$60.4$60$85
Change-33.02%+1.14%+0.47%+42.33%

Analyst Ratings

The average analyst rating for Inspire Medical Systems stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy443334
Buy110000
Hold101011121211
Sell001111
Strong Sell000011
Total151515161717

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Hold
Maintains
$54$60
HoldMaintains$54$60+0.47%Aug 4, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$55$65
BuyMaintains$55$65+8.84%Aug 4, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Reiterates
$65$75
BuyReiterates$65$75+25.59%Aug 4, 2026
Truist Financial
Truist Financial
Hold
Reiterates
$54$62
HoldReiterates$54$62+3.82%Aug 4, 2026
Wells Fargo
Wells Fargo
Hold
Maintains
$56
HoldMaintains$56-6.23%Aug 4, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
853.46M
from 911.98M
Decreased by -6.42%
Revenue Next Year
884.17M
from 853.46M
Increased by 3.60%
EPS This Year
1.22
from 2.42
Decreased by -49.66%
EPS Next Year
1.52
from 1.22
Increased by 24.41%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
233.39M407.86M624.80M802.80M911.98M853.46M
Revenue Growth
102.28%74.75%53.19%28.49%13.60%-6.42%
Gross Profit
200.12M341.74M528.22M679.82M778.76M734.44M
Gross Margin
85.74%83.79%84.54%84.68%85.39%86.05%
Operating Income
-39.85M-47.59M-40.27M36.08M50.95M32.19M
Net Income
-42.04M-44.88M-21.15M53.51M145.42M-208.47K
EPS
----2.421.22
EPS Growth
----38.29%-49.66%
Forward PE
---114.3757.1449.02
Free Cash Flow
-10.69M17.43M27.63K62.72M54.50M120.07M
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High861.9M
Avg853.5M
Low840.1M

Revenue Growth

Revenue Growth202620272028
High
-5.5%
Avg
-6.4%
Low
-7.9%

EPS Forecast

EPS202620272028
High1.33
Avg1.22
Low0.86

EPS Growth

EPS Growth202620272028
High
-45.0%
Avg
-49.7%
Low
-64.5%